Skip Navigation

Radiation Protection Dosimetry 2004 109(3):249-252; doi:10.1093/rpd/nch041
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Traino, A. C.
Right arrow Articles by Lazzeri, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traino, A. C.
Right arrow Articles by Lazzeri, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Radiation Protection Dosimetry Vol. 109 No. 3 © Oxford University Press 2004; all rights reserved

Technical Note

A minimally invasive method to evaluate 131I kinetics in blood

A. C. Traino1,*, F. Di Martino1, G. Boni2, G. Mariani2 and M. Lazzeri1

1 U.O. Fisica Sanitaria, Azienda Ospedaliera Universitaria Pisana, Via Roma 67, I-56125 Pisa, Italy
2 Centro Regionale di Medicina Nucleare, Azienda Ospedaliera Universitaria Pisana, Via Roma 67, I-56126 Pisa, Italy

* Corresponding author: c.traino{at}ao-pisa.toscana.it

The dose limiting factor for 131I therapy in patients with thyroid cancer is myelotoxicity, thus an accurate determination of radioiodine activity in the red marrow is of paramount importance. The reference method for red marrow dosimetry in radiometabolic therapy is based on the measurement of radioiodine kinetics, particularly the activity/time curve in blood. Such a measurement requires withdrawal of blood samples at various times after 131I administration. This procedure involves some potential risk from the radiation protection point of view, such as possible contamination of personnel with blood and disposal of the radioactive blood samples (and syringes). We present here a minimally invasive method to evaluate radioiodine kinetics in the blood, which only requires one blood sample and a set of measurements on the patient's thigh made with a collimated NaI(Tl) probe. The method has been validated in four patients treated with 131I for thyroid cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.